Introduction: We present the Brain-Age Score (BAS) as a magnetic resonance imaging (MRI)-based index for Alzheimer's disease (AD). We developed a fully automated framework for estimating the BAS in healthy controls (HCs) and individuals with mild cognitive impairment (MCI) or AD, using MRI scans.
Methods: We trained the proposed framework using 385 HCs from the IXI and OASIS datasets and evaluated 146 HCs, 102 stable-MCI (sMCI), 112 progressive-MCI (pMCI), and 147 AD patients from the J-ADNI dataset. We used a correlation test to determine the association between the BAS and four traditional screening tools of AD: the Mini-Mental State Examination (MMSE), Clinical Dementia Ratio (CDR), Alzheimer's Disease Assessment Score (ADAS), and Functional Assessment Questionnaire (FAQ). Furthermore, we assessed the association between BAS and anatomical MRI measurements: the normalized gray matter (nGM), normalized white matter (nWM), normalized cerebrospinal fluid (nCSF), mean cortical thickness as well as hippocampus volume.
Results: The correlation results demonstrated that the BAS is in line with traditional screening tools of AD (i.e., the MMSE, CDR, ADAS, and FAQ scores) as well as anatomical MRI measurements (i.e., nGM, nCSF, mean cortical thickness, and hippocampus volume).
Discussion: The BAS may be useful for diagnosing the brain atrophy level and can be a reliable automated index for clinical applications and neuropsychological screening tools.
Keywords: ADAS; Alzheimer's disease; CDR; FAQ; MMSE; anatomical MRI measurements; brain-age score; mild cognitive impairment; neuropsychological screening; structural MRI.
© 2018 National Center of Neurology and Psychiatry. Brain and Behavior published by Wiley Periodicals, Inc.